Jonathan Tegge - 12 Dec 2022 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role: Interim CFO
Signature: /s/ Eric Adams, attorney-in-fact for Mr. Jonathan Tegge
Issuer symbol: INM
Transactions as of: 12 Dec 2022
Net transactions value: $0
Form type: 3
Filing time: 15 Dec 2022, 18:10:59 UTC
Next filing: 19 Dec 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney